TNB-486 induced T-cell dependent killing of CD19-positive B-cell leukemia and lymphoma cells while inducing minimal cytokine secretion... Oct 05
Around 50 crore doses of COVID-19 vaccine expected to be ready by July 2021: Dr. Harsh Vardhan... Oct 05
India recorded 940 deaths, taking the national death toll to 1,01,782... Oct 05
UK government sources says a full vaccine roll-out programme for adults could take six months or less after approval... Oct 05
Impact BioMedical to begin efficacy testing of pan-coronavirus vaccine under new wholly owned subsidiary Innate Immune, Inc. ... Oct 05
This 220-bedded super speciality hospital has been dedicated as a COVID hospital to the nation... Oct 05
The Chinese vaccine company Sinovac Biotech has sought co-financing from Bangladesh for a phase-3 clinical trial of its COVID-19 vaccine... Oct 05
Harvey J Alter, Charles M Rice & Michael Houghton win Nobel Prize in Medicine for discovery of Hepatitis C virus ... Oct 05
Launching the anti-pollution campaign for a clean and green Delhi, he said, pollution can prove fatal in the Covid-19 pandemic situation. ... Oct 05
The Indian Army chief and the Foreign Secretary along with Ambassador of India to Myanmar, Saurabh Kumar, called on Suu Kyi at Naypyitaw today during ... Oct 05
A lot is going around the world from US President Donald Trump getting infected with COVID to Auckland lifting the restrictions placed to Increasing number ... Oct 05
Zydus Healthcare Limited announced that it is launching the anti-diabetic Dapagliflozin tablets in India upon its patent expiry under the brand name ‘Dapaglyn’... Oct 05
... Oct 05
Certain factors attributed in medical literature to death in frontline doctors include lack of adequate PPE, an inadequate technique of donning and doffing of PPE, ... Oct 05
US FDA approved for the first-line treatment of adults with malignant pleural mesothelioma that cannot be removed by surgery... Oct 05
Neutral Atom launches Spectra360 to fight against COVID-19: A UV disinfecting tower ... Oct 05
Dr. Reddy’s Laboratories Ltd. has joined the SBTi becoming the first Indian and the third Asian pharma company to further minimize environmental impact... Oct 05
Findings showed that the 2-drug regimen (2DR) of dolutegravir plus lamivudine continued to offer non-inferior efficacy... Oct 05
-Advertisements-